Interactions and molecular structure of cardiolipin and β2-glycoprotein 1 (β2-GP1)
- 1 November 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 102 (2) , 373-378
- https://doi.org/10.1111/j.1365-2249.1995.tb03792.x
Abstract
SUMMARY: β2-GP1 is a serum protein which influences binding of anticardiolipin antibodies to cardiolipin, may influence induction of these antibodies in animals and may play a role in anticardiolipin-mediated thrombosis. Various investigators have proposed that when β2-GP1 binds cardiolipin, structural alterations occur in one or both molecules, resulting in exposure of new epitopes for anticardiolipin binding, but there has been no proof that such alterations occur. Utilizing Fourier transform infrared spectroscopy, this study analysed the structure of cardiolipin and β2-GP1 alone, then mixed with each other. For pure cardiolipin, analysis of the CH2 stretching, scissoring and carbonyl bands suggested this molecule assumes a hexagonal crystal lattice packing structure in both anhydrous and aqueous samples. Based on the second derivative analysis of the amide 1 band from the β2-GP1 protein backbone, as well as Fourier self-deconvolution and curve fit algorithms, β2-GP1 was calculated to contain 18% turns, 37%α-helix, and 45%β-sheet structure. β2-GP1 binding with cardiolipin results in a significant change in the conformation as well as geometry of the lipid and protein components. This is indicated by a broadening of the CH stretching band and a marked shift in intensity of the carbonyl band of cardiolipin, indicating less hydrogen bonding. There was a decrease in β-sheet structure of β2-GP1 from 46% to 23% and appearance of 26% to 28% random structure. These findings indicate that mixing β2-GP1 with cardiolipin results in profound changes in both molecules which might explain the effect of β2-GP1 on anticardiolipin binding activity.Keywords
This publication has 29 references indexed in Scilit:
- What is the "true" antigen for antiphospholipid antibodies?The Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Protein secondary structures in water from second-derivative amide I infrared spectraBiochemistry, 1990
- ANTIPHOSPHOLIPID ANTIBODIESBritish Journal of Haematology, 1990
- Effects of the Lupus Anticoagulant in Patients with Systemic lupus Erythematosus on Endothelial Cell Prostacyclin Release and Procoagulant ActivityJournal of Investigative Dermatology, 1988
- Anticardiolipin antibodies: isotype distribution and phospholipid specificity.Annals of the Rheumatic Diseases, 1987
- Analysis of the hexagonal II phase and its relations to lipidic particles and the lamellar phase A freeze-fracture studyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1981
- Characterization by infrared spectroscopy of the bilayer to nonbilayer phase transition of phosphatidylethanolaminesBiochemistry, 1981
- The gel phase of dipalmitoyl phosphatidylcholine. An infrared characterization of the acyl chain packingBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- Polymorphic phase behaviour of cardiolipin as detected by 31P NMR and freeze-fracture techniques. Effects of calcium, dibucaine and chlorpromazineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1978